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Conclusion: A significant “umber of &al lesions with angiographic stenosis> 70% an? 
associated with a physiologic nonischemic threshold (i.e. FFR -> 0.75). Ostial lesions 
without evidence of ischemia should undergo physiologic testing before interventions. 
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1149-l 91 Cutting Balloon Atherotomy Is Associated With 
Decreased Stent Utilization 
Jeffrey A. Goldstein. Jason H. Rogers, Ivan P. Casserly. John M. Lasala, Howard I. Kurz. 
Jasvindar Singh, Richard G. Bach, Morton R. Rinder, Megumi Taniuchi, Washington 
University School of Medicine, Saint Louis, MO 
Background: Cutting balloon atherotomy (CBA) achieves luminal gain by creating con- 
trolled fissuring of coronary plaques. In a retrospective comparison of CBA to other tech- 
niques for treatment of non-intrastent lesions at Barnes-Jewish Hospital, CBA was 
associated with decreased need for stent implantation (50% vs. 66.4%), greater angio- 
graphic and clinical success (99.6% vs. 97.9% and 99.3% vs. 95.9%), and no difference 
in 1 and 9 month target vessel revascularization (TVR) (1.6% vs. 0.9%, and 15% vs. 
12%, respectively). The Cuffing Balloon as Sole Revascularization Trial compares CBA 
with conventional balloon angioplasty (POBA) as the primary treatment for non-intrastent 
lesions. Methods: Patients undergoing percutaneous revascularization for native coro- 
nary artery lesions are randomized to CBA or POBA as primary treatment. Provisional 
stenting is indicated for z-35% residual stenosis, grade B or greater dissection, or throm- 
bus. The primary endpoint is stent implantation for sub-optimal results. Secondary end- 
points include in-hospital MACE and 1 and 9 month TLR. Results: Twenty-two patients 
have been randomized to the CBA group and 17 patients to the POBA group. Clinical 
characteristics. vessels treated, and lesion types are similar between the two groups. To 
date, CBA has achieved greater angiographic success as primary therapy (67.0% vs. 
57.7%; p=O.O2), with fewer dissections (22.2% vs. 45.5%, p=NS) compared to conven- 
tional angioplasty. CBA is associated a decreased need for stent implantation (27.6% vs. 
61.6%; p<O.OOl). Despite lower stent utilization in the CBA group, there is no difference 
in final stenosis (14.5% vs. 14.0%). 
Conclusions: As primary therapy, CBA appears to achieve greater angiographic suc- 
cess with decreased need for stent implantation compared to POBA. Updated enrollment 
with cost analysis, 1 month and 9 month outcomes will be presented. A model for com- 
paring cost-benefit of CBA compared to implantation of drug-coated stents will be dis- 
cussed. 
1149-192 Diabetes Does Not Add to the Increased Six-Month 
Mortality Associated With Increase in CK-MB After 
Percutaneous Coronary intervention 
Sanieev Puri, Bernard R. Chaitman, Jeffrey A. Gavard, Shunta Sakai, Karen Stocke. Leif 
Erhardt. Eric Chi. Andreas Jessel, Richard Gallo, Pierre Theroux, for the GUARDIAN 
Investigators, St. Louis University School of Medicine, St. Louis, MO 
Background: Increased CK-MB release after percutaneous coronary intervention (PCI) 
is associated with increased mortality. It is not known if the prognosis of diabetic (D) pts 
with increased CK-MB levels after PCI is different than nondiabetic (ND) pts. 
Methods: The GUARDIAN trial contained 2,173 PCI pts who had prospectively acquired 
baseline clinical and post-PC1 CK-MB and ECG data. The incidence and B-month mortal- 
ity associated with different levels of CK-MB were compared between 516 D pts and 
1,657 ND pts. 
Results: The incidence of peak CK-MB elevation in D pts was not greater than in ND pts 
(table). The D subgroup was older (median age 64.0 vs. 62.0, p.zO.05); had more females 
(33.3% vs. 22.7%, p<O.OOl) and fewer whites (66.6% vs. 94.5%, p<O.OOl); was more 
obese (media” body mass index 29.0 vs. 27.3. p<O.OOl): had a higher systolic blood 
pressure (median 134.0 vs. 130.0, p<O.OOl); and was more likely to have a history of 
heart failure (15.7% vs. 7.0%. pcO.OOl), cerebrovascular disease (11.4% vs. 6.0%, 
p<O.O5), and peripheral vascular disease (16.0% vs. 9.6%. pcO.001) than the ND sub- 
group. The 6-month mortality rates in D were usually slightly greater than in ND at any 
particular peak CK-MB ratio cutoff, but “one were statistically significant (table). 
Conclusion: The incidence and magnitude of CK-MB leaks following PCI is no greater in 
D than in ND. D have a more adverse risk profile than ND, but for any given level of peak 
CK-MB release post-PCI, diabetes does not significantly elevate 6-month mortality risk. 
Incidence of Peak CK-MB Ratio in PCI 6-Month Mortality in PCI Patients by Peak 
Patients (%) CK-MB Ratio Cutoffs (%) 
<l 51<3 z33<5 s >I0 <1 ULN >3ULN >5ULN >lOULN 
UL ULN ULN <lO ULN 
N ULN 
Diabeti 67. 21.3 5.0 2.9 2.9 3.1 3.6 6.7 6.7 
c 6 
Non- 63. 23.5 5.7 3.7 3.1 1.4 3.6 5.3 5.9 
diabeti 9 
c 
p=o.57 p=o.c6 p=1.00 p=1.00 p=l.OO 
1149-193 Long-Term Outcome of Patients With Prior 
Percutaneous Revascularization Undergoing Repeat 
Coronary intervention 
Heidar Arjomand, David R. Holmes, James T. Wilierso”, Bassam Roukoz. Satish 
Surabhi, Andrev Espinoza. Daniel McCormick, Zoltan G. Turi, Sheldon Goldberg, Drexel 
University College of Medicine, Philadelphia, PA, Mayo Clinic, Rochester, MN 
Background: Patients (pts) with a history of prior percutaneous coronary revasculariza- 
tion (PCR) are often excluded from clinical trials. As a result, there is limited data on the 
outcome of these pts undergoing repeat coronary intervention. 
Method: Of 11,262 pts undergoing percutaneous coronary intervention (PCI) in the Pre- 
vention of Restenosis with Tranilast and its Outcomes (PRESTO) trial, 3,495 pts had his- 
tory of prior PCR, 2l3 of whom had prior stent placement. We compared the outcome of 
these pts with 7,767 pts with de “ova lesions. 
Results: Mean age was 60 yrs in both groups. Pts with prior PCR were more likely to 
have DM (26% vs 22%, P < O.OOl), HTN (70% vs 57%, p < O.OOl), hypercholesterolemia 
(66% vs 47%. p < O.OOl), prior Ml (56% vs 31%, p < O.OOl), and prior CABG (23% vs 
9%, p < O.OOl), and less likely to have new-onset angina (21% vs 26%, p < O.OOl), signif- 
icant EKG changes (6% vs ll%, p < O.OOl), or be current smokers (17% vs 25%, p < 
0.001). Angiographic features in pts with and without history of PCR. respectively, 
included: ostial lesions (10% vs 6%. p < O.OOl), total occlusion (6% vs IO%, p < 0.001). 
ejection fraction (60.9% vs 56.6%, p < O.Ol), and LAD location (31% vs 41%, p < 0.001). 
Ilb/llla was used in 39% and 35% respectively (p < 0.001). In-hospital rates of cardiac 
events were low and similar. Kaplan-M&r estimates of events at 9 months an? shown 
(table). 
Conclusions: Despite similar in-hospital outcomes, patients with a history of prior PCR 
have a significantly lower event-free suwival at B-month follow-up. 
Kaplan-M&r Estimates of Cardiac Events at 9-month Follow-up 
Variable Prior PCR No Prior PCR 
Estimate (95% Cl) Estimate (95% Cl) 
P value 
Death 1.7(1.1-2.2) 1.2 (0.9-l .6) 0.059 
Ml 2.0 (1.4-2.5) 1.3 (1.0-l .6) 0.016 
CABG 7.6 (6.6-6.7) 3.2 (2.7-3.7) < 0.001 
Death or Ml 3.4 (2.6-4.1) 2.5 (2.0-2.9) 0.012 
Death, MI. or CABG 10.1 (6.9-11.4) 5.4 (4.7-6.0) < 0.001 
1149-194 Rupture of the External Elastic Lamina Increases 
Plaque Neovascularization After Coronary Angioplasty 
in the Swine Model 
Dario Echeverri German Santamaria, Valentin Fuster, William N. O’Connor, Pedro R. 
Moreno, University of Kentucky, Lexington, KY, Fundacion Cardio-lnfantil, Bogota, 
Colombia 
Background: While plaque “eovascularization (NV) is associated with neointimal prolif- 
eration alter vessel wall injury, rupture of the external elastic lamina (EEL) may increase 
this angiogenic response. We tested the hypothesis that plaque NV is increased in coro- 
nary lesions with EEL rupture after balloon angioplasty in the swine model. 
Materials and Methods: Thirty-nine histological sections from ballooned coronary artery 
angioplasty segments were studied after 6 weeks of barotrauma. Rupture of EEL was 
defined as extensive tissue interruption along the media-adventitia interface on 40x light 
microscopy. Neovessels were defined as tubuloluminal anti-vWF positive capillaries rec- 
ognized in immunostained sections by light microscopy. Morphometric measurements 
wsre performed by computerized planimetry. 
Results: Plaque NV was increased in lesions with rupture of EEL (Table). Neointimal 
area was increased and lumen area was decreased in lesions with rupture of EEL 
(Table). EEL area was similar in both groups. Multiple regression analysis identified rup- 
ture of EEL as a” independent predictor for plaque NV (RR=l9.6; 95% Cl=2.4-37). 
Conclusion: Neovascularization is increased in coronary plaques with rupture of the 
external elastic lamina following vessel wall injury. This angiogenic response is associ- 
ated with increased neointima formation and reduced lumen ares. Thus, novel anti- 
angiogenic therapies may offer a” alternative option for the prevention of restenosis. 
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EEL Rupture (16) Normal EEL (21) P value *p<O.O5, tp<O.Ol (unpaired t-test, compared to previous step) 
Plaque Neovessels (total count) 52 * 32 
Neointimal Area (mm2) 2.4 * 1.4 
Lumen Area (mm2) 1.6 * 0.7 
EEL Area (mm2) 4.76 * 1.2 
25*2u 
1.5*1 
2.5 * 0.9 
4.88 * I .3 
0.004 
0.037 
0.001 
0.7 
1149-195 Physiologic Assessment of Serial Lesions: Comparison 
of Present Methodologies 
A P (mmHg) v (cm/s) FFR CVR SRv(mmHg/cm/s) 
h-x/ 35.6 f 16.6 30.3 * 18.5 0.62 * 0.17 1.66 f 0.54 2.05 zt 2.17 
&?/loon 16.1 * 9.07 44.6 * 11.2t 0.60~O.lOt 2.14 * 0.36’ 0.46 * 0.3lt 
Stenf 11.2 * 7.9 59.1 f 19.0* 0.88 * 0.09 2.88 * 0.62t 0.22 f 0.19 
UPstent 11.2 * 3.3 61.6 f 20.3 0.6a*o.l1 2.76 * 0.40 0.21 r 0.25 
Luis Gruberq Eugenia Nikolsky, Hylton Miller, Carlo Di Mario, Martin Leon, Rafael 
Beyar, Rambam Medical Center, Haifa, Israel, Tel Aviv Medical Center, Tel Aviv, Israel POSTER SESSION 
Background: FFR is a well-established hemodynamic parameter for physiological 
assessment of the severity of a single coronary lesion. We compared a novel algorithm 
to assess the individual FFR of each lesion in a vessel with serial lesions to the current 
method which requires multiple hyperemic injections and wedge pressure measure- 
ments. 
Methods: 26 patients undergoing intervention for two (n=24) or three (n=2) tandem 
lesions were studied. Basal and hyperemic pressure curves were measured distal to 
each of the serial stenoses. At least one lesion was treated in each patient based on 
angiographic evaluation. Wedge pressure was measured during balloon inflation for 
treatment of one of the lesions and used lo calculate the wedge based value of FFR 
(FFRwedge). FFRsmarlflow was derived from rest pressure across each of the serial 
lesions and one hyperemic pressure across all lesions. 
Results: Individual FFR obtained by both methods were highly correlated (wO.96, 
p<O.OOl). The correlation was significant for both the proximal lesion (r=0.93, pcO.001) 
and for the distal lesion (r= 0.99, pcO.001). Combining the proximal and distal lesions, 
there was no significant difference between the two methods (p= 0.733). 
Conclusions: FFRsmartflow allows real-time and accurate evaluation of lesion specific 
FFR in vessels with multiple serial lwons with only baseline pressure measurements 
between lesions and one distal measurement with adenosine injection. 
1150 Novel Sent Designs and Coatings 
Tuesday, April 01, 2003, 9:00 a.m.-l 1:OO a.m. 
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1150-178 First Clinical Experience With 17- Estradiol-Eluting 
BiodivYsio Matrix LO Stent to Prevent Restenosis in 
De-Novo Native Coronary Arteries: Six-Month Clinical 
Outcomes and Angiographic Follow-Up From the 
EASTER Trial 
Alexandre A. Abizaid, Gishel New, Andrea S. Abizaid, Marco Costa, Vinicius Vaz, 
Nicholas Kipshidze, Rodolfo Staico, Faust0 Feres, Roxana Mehran, lbraim Pinto, Gary 
Roubin, Sriram lyer, Jefrrey Moses, Marlin Leon, Amanda Sousa, Jose Eduardo M. 
Sousa, Institute Dante Pauanese of Cardiology, Sao Paula, Brazil, Cardiovascular 
Research FoundationlLenox Hill Hospital, New York, NY 
I- 
R=0.96 
0.9 - 
o -first lesion, R=0.93 
*- second lesioh, R=0.99 
Background: A recent study in the porcine coronary model demonstrated that 173 
sstradiol-eluting atents reduce neointimal formation by 40%. Whether 17-p estradiol has 
a similar vasculoprotective effect in the clinical setting is not known. 
Objective: To determine the safety of 17-p estradiol-eluting PC-coated stent (Bidi- 
vysioTM) in the treatment of de nova native coronary stenosis.: and the efficacy of this 
strategy on B-month binary restenosis and late loss as assessed by angiography. 
Methods: Thirty patients were studied in this prospective pilot registry. All pawn& 
received a single 15 or 16 mm drug-eluting Bidivysio TM stent. The average drug concen- 
tration was approximately 2.54p@mm’ as previously studied in the animal model. 
Results: Mean age was 61+12 years, 70% were men, 10% diabetics, 27% had hyperc- 
holesterolemia, and 44% previous MI. Lesion length was 9.1+2.4mm, and reference yes- 
sel diameter was 2.76+0.56mm. Angiographic results are shown in table: 
/ 
4 
0.3 ’ 
0.3 0.4 0.5 0.6 0.7 0.8 0.9 
FF?wlrJe 
Post intervention In-stent In-segment 
. MLD (mm) 2.44 * 0.52 2.04 f 0.43 
. Diameter stenosis (%) 13.6 * 10.4 23.4 * 10.9 
Follow-up 
1149-196 The Importance of Combined Pressure and Flow 
Velocity Measurements to Evaluate the Hemodynamic 
Effect of Percutaneous Coronary Interventions 
Maria Siebes, Ban-Jan Verhoeff, Martijn Meuwissen, Jos A. Spaan, Jan J. Piek, 
Academic Medical Center, Amsterdam, The Netherlands 
. MLD (mm) 1.69 * 0.57 1.76 zt 0.56 
_ Diameter stenosis (%) 28.2 * 14.6 30.5 + 14.9 
_ Late loss (mm) 0.54 + 0.44 0.31 * 0.38 
Binary restenosis occurred in 2 pts (6.6%) and ischemic driven target vessel revascular- 
izatlon in one (3.3%) with no additional major adverse cardiac events 
Conclusion: The implantafion of 17-p estradiol-eluting BiodlvysioTM stent was safe and 
associated with low binary restenosis and clinical recurrence. These data suppod the 
antiproliferative properties of estrogen and warrant further investigation in a larger ran- 
domized trial. 
Background: We simultaneously assessed distal flow velocity (v) and pressure with a 
novel 0.014” dual-sensor guide wire to determine the magnitude and sequence of hemo- 
dynamic changes that contribute to the outcome of percutaneous coronary intervention 
(PCI). 
Methods: Aortic pressure, Y, and distal pressure were measured after an i.c. bolus of 
adenosine in 12 patients with a single de nova lesion (56.4 * 12.5% diameter stenosis) 
before and after stepwise executed PCI (balloon angioplasiy, stenting and upsized stew 
ing guided by intravascular ultrasound). Pressure gradient (AP = aortic-distal pressure) 
and vat maximal hyperemia were compared per intervention step, as well as descriptors 
of functional stenosis severity, i.e., fractional (FFR) and coronary (CVR) flow reserve. 
and hyperemic stenosis resistance index (SRv=AP/v). 
Results: An initial large decrease inAP was followed by non-significant changes. In con- 
trast, v continued to increase significantly after the initial step. Upsized stenting caused 
variable results and slightly reduced CVR. Pressure-based parameters were least sensi- 
tive after the initial dilation, while SRv combined the sensitivity of AP and Y for all steps of 
PCI-induced hemodynamic changes. 
Conclusion: Stepwise executed PCI affects AP and v to variable degrees, with changes 
in pressure-based variables diminishing quickly. Assessment of PCI in hemodynamic 
terms benefits from combining pressure and velocity information and SRv may thus pro- 
vide a valuable prognostic tool. 
1150-179 Estradiol Coated Stents for the Prevention of 
Restenosis in Native Coronary Arteries: Results From 
the Randomized Multicentric Study EASTER 
Flavio Airoldi, Carlo Di Mario, Goran Stankovic, Carlo Briguori, Patrizia Presbitero. Flavio 
Ribichini, Vaaailia Spanos, Matte0 Montorfano, Angela Ferrari, Antonio Colombo, San 
Raffaele Hospital, EM0 Centro Cuore Columbus, Universita’ di Novara, lstituto Clinic0 
Humanitas, Milan, Italy 
Introduction: In vitro and animal models indicate that lip-&radio1 inhibits intimal smooth 
muscle cell proliferation and migration and accelerates re-endothelization after PTCA. 
This study prospectively and randomly compares stents loaded with lip-&radio1 (Biodi- 
vYsio DD Matrix, Biocompatibles, Galway, Ireland) to bare metal stents (BiodwYsio OC) 
in reducing restenosis rate. Methods we repolt the in-hospital and l-month follow-up 
(FU) results of the 2 different type of stents in de nova lwons located on native coronary 
arteries. In the study 61 patients with 111 lesions 54 (46%) in the estrogen arm and 57 
(52%) in the control arm. Complex lesions (82, C type ACClAHA) were 42% and 44% in 
the estrogen and in the control arm respectively (p=n.s.). No statistically significant differ- 
ences were noted between the 2 groups in baseline angiographic measurements (basal 
ref. diam. 2.69r 0.60 mm vs 2.95* 0.57 mm; MLD 0.97i 0.61 mm vs 1.02~ 0.56 mm: 
lesion length 11.7* 6.5 mm vs 13.9+ 9.6 mm I” the estrogen and in the control group 
respectively). nor after stenting (Final MLD 0.97+ 0.61 mm vs 1.02* 0.56 mm m the 
estrogen and in the control group respectively). After discharge, all patients have been 
